Post-remission treatment strategy for acute myeloid leukemia patients in low-or intermediate-risk group
-
-
关键词:
- 白血病,髓细胞,急性 /
- 治疗
-
Key words:
- acute myeloid leukemia /
- treatment
-
-
[1] THOMAS X,ELHAMRI M,RAFFOUX E,et al.Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission:the ALFA-9802 study[J].Blood,2011,118:1754-1762.
[2] LOWENBERG B,PABST T,VELLENGA E,et al.Cytarabine dose for acute myeloid leukemia[J].N Eng J Med,2011,364:1027-1036.
[3] BURNETT A K,RUSSELL N H,HILLS R K,et al.Optimization of chemotherapy for yonger patients with acute myeloid leukemia:results of the medical research council AML15 trial[J].J Clin Oncol,2013,31:3360-3368.
[4] HENGEVELD M,SUCIU S,KARRASCH M,et al.Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years:final results of the randomized phased III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia cooperative Groups[J].Ann Hematol,2012,91:825-835.
[5] KEATING A,DASILVA G,PÉREZ W S,et al.Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete:a registry study from the Center for International Blood and Marrow Transplantation Research[J].Haematologica,2013,98:185-192.
[6] ETO T,TAKASE K,MIYAMOTO T,et al.Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission[J].Int J Hematol,2013,98:186-196.
[7] STAUDINGER M,HUMPE A,GRAMATZKI M.Strategies for purging CD96+ stem cells in vitro and in vivo:New avenues for autologous stem cell transplantation in acute myeloid leukemia[J].Oncoimmunology,2013,2:e24500.
[8] HUANG X J,ZHU H H,CHANG Y J,et al.The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate-or high-risk aucte myloid leukemia in first complete remission[J].Blood,2012,119:5584-5590.
[9] BURNETT A K,GOLDSTONE A,HILLS R K,et al.Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remisson[J].J Clin Oncol,2013,31:1293-1301.
[10] CHEN J,WANG R X,CHEN F,et al.Combination of a haploidentical SCT with an unrelated cord blood unit:a single-arm prospective study[J].Bone Marrow Transplant,2014,49:206-211.
[11] SANCHEZ-ORTEGA I,ARNAN M,PATINO B,et al.Early engraftment and full-donor chimerism alter single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia[J].Bone Marrow Transplant,2014,49:145-147.
[12] MIYAWAKI S,OHTAKE S,FUJISAWA S,et al.A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremissoin therapy for acute myloid leukemia in adults:the JALSG AML201 Study[J].Blood,2011,117:2366-2372.
[13] GUO M,HU K X,YU C L,et al.Infusion of HLA-mismatched periperal blood stem cells pmproves the outcome of chemotherapy for aucte myeloid leukemia in elderly patients[J].Blood,2011,117:936-941.
-
计量
- 文章访问数: 234
- PDF下载数: 97